Literature DB >> 3704444

Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective.

R Broughton, V Valley, M Aguirre, J Roberts, W Suwalski, W Dunham.   

Abstract

The main disabling symptom of narcolepsy-cataplexy is shown to be the unrelenting excessive daytime sleepiness (EDS) based upon controlled studies of socioeconomic effects and the poor response to treatment. Objective performance deficits mainly involve tests of ability to sustain performance on repetitive boring tasks and are reversible by improved alertness. Physiologically, EDS is seen to represent relatively slow waxing and waning of alertness rather than punctate microsleeps. Evidence is provided for complex cerebral evoked potentials (P300, contingent negative variation) being very sensitive EDS measures comparable to the multiple sleep latency test (MSLT). EDS appears to have qualitatively somewhat different forms mainly reflecting pressure for REM sleep (REM sleepiness) or pressure for NREM sleep (NREM sleepiness), which have different effects on cerebral evoked potentials as well as subjective and objective (MSLT) differences. It is argued that in pathophysiological terms narcolepsy may best be considered a disease of state boundary control.

Entities:  

Mesh:

Year:  1986        PMID: 3704444     DOI: 10.1093/sleep/9.1.205

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  19 in total

1.  Abnormal sleep/wake dynamics in orexin knockout mice.

Authors:  Cecilia G Diniz Behn; Elizabeth B Klerman; Takatoshi Mochizuki; Shih-Chieh Lin; Thomas E Scammell
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

Review 2.  Sleep neurobiology from a clinical perspective.

Authors:  Rodrigo A España; Thomas E Scammell
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

3.  Autonomic function in narcolepsy: power spectrum analysis of heart rate variability.

Authors:  L Ferini-Strambi; A Spera; A Oldani; M Zucconi; A Bianchi; S Cerutti; S Smirne
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

4.  Functional involvement of cerebral cortex in human narcolepsy.

Authors:  A Oliviero; G Della Marca; P A Tonali; F Pilato; E Saturno; M Dileone; V Versace; G Mennuni; V Di Lazzaro
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

Review 5.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

Review 6.  Sleep state switching.

Authors:  Clifford B Saper; Patrick M Fuller; Nigel P Pedersen; Jun Lu; Thomas E Scammell
Journal:  Neuron       Date:  2010-12-22       Impact factor: 17.173

Review 7.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

8.  Behavioral state instability in orexin knock-out mice.

Authors:  Takatoshi Mochizuki; Amanda Crocker; Sarah McCormack; Masashi Yanagisawa; Takeshi Sakurai; Thomas E Scammell
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

9.  The economic consequences of narcolepsy.

Authors:  Poul Jennum; Stine Knudsen; Jakob Kjellberg
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

10.  Increased heart rate variability but normal resting metabolic rate in hypocretin/orexin-deficient human narcolepsy.

Authors:  Rolf Fronczek; Sebastiaan Overeem; Robert Reijntjes; Gert Jan Lammers; J Gert van Dijk; Hanno Pijl
Journal:  J Clin Sleep Med       Date:  2008-06-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.